Dr. Silvy Lachance
Titles
- Director - Medical and administrative; Stem Cell Transplant Program-Maisonneuve-Rosemont Hospital; Université de Montréal.
- Director – Fellowship Program in Stem Cell Transplantation – Université de Montréal.
- Clinical Researcher – Haematology and Medical Oncology program; Maisonneuve-Rosemont Hospital.
- Associate Professor of Medicine, Université de Montréal.
- Haematologist, Maisonneuve-Rosemont Hospital.
Training
- Ph.D. Medicine: Université de Sherbrooke, 1987.
- Licence of the Medical Council of Canada, 1988.
- Fellow, Royal College of Physician and Surgeon of Canada (FRCPC), Internal medicine, 1991.
- Fellow, Royal College of Physician and Surgeon of Canada (FRCPC), Hematology, 1992.
- Diplôme d’étude avancée (DEA) in Immunology, Institut Pasteur, Paris, France, 1994.
- Fellow in Stem Cell Transplant; clinical and biological, Université Henri Mondor, Paris, France.
- Clinical research on biological predictive factors of acute graft-versus-host-disease.
Research and teaching
Main domain of research
- Stem cell transplant
- Graft-versus-host-disease
- Malignant haematology
Research projects
- Dosage of helper T-Cell precursors (p-HTL) by limiting dilution analysis to study their implication in acute graft-versus-host disease and graft-versus leukemia reaction. Immunology Laboratory, CHU Henri Mondor, Créteil, France, under the direction of Professeur Jean-Pierre Farcet (1994-1995).
- Dosage of cytotoxic T-Cell precursors (p-CTL) to study of their predictive value in GVH and GVL reaction.. Service d’immunologie-biologie, CHU Henri Mondor, Créteil, France (1993-1994).
Research grants
$120,000 between 1993 and 1995: Fellowship.
Other
Participation as investigator or co-investigator to numerous clinical protocols in malignant hematology and stem cell transplant (USA and Canada).
Influential
Committees
- Treasurer, executive committee of the Association des médecins hématologues et oncologues du Québec (AMHOQ)– 2005 – present.
- Secretary, executive committee of the Canadian Blood and Marrow Transplant Group – 2009 to present
- Elected member – Advisory Board representative, Canadian Blood and Marrow Transplant Group. (2001 - présent)
- President of jury – Hematology certification board – Collège des médecins du Québec.(2003-2006)
- Vice-President of jury – Hematology certification board. – Fédération des médecins spécialistes du Québec. (1998-2002)
- President CME committee, AMHOQ. (1999-2001)
- Consultant :Recommendations of the Canadian Consensus Group on the management of Chronic Myelogenous Leukemia. (2004)
- Member organising committee – Canadian society of Cancer – Erythropoietin Cancer Research Conference, Toronto, Canada. (2004)
- Vice-president – Organising committee – Canadian Blood and Marrow Transplant Group – Congrès annuel 2000 – Québec.
Scientific presentations
- University conferences and affiliated centres: 30.
- National and international conventions: 20.
Awards and honours
- Douglas G. Kinnear Award. McGill University. For excellence in teaching in medicine. (2003)
- Samuel H. Mc Laughlin’s Fourdation Awards. Fellowship in stem cell transplant. (1993-1995).
